Ulcerative colitis for non-gastroenterologists

Authors

  • Nicolás Zuluaga Arbeláez Universidad CES https://orcid.org/0000-0002-7648-3462
  • Elsy Cristina Sierra Vargas Universidad de Antioquia
  • Juan Camilo Díaz Coronado Universidad CES
  • Luis Gonzalo Guevara Casallas Universidad CES

DOI:

https://doi.org/10.21615/cesmedicina.34.3.2

Keywords:

Ulcerative colitis, Intestinal diseases, Diagnosis, Therapeutics

Abstract

Ulcerative colitis is a chronic inflammatory bowel disease of idiopathic etiology and multifactorial pathophysiology. It is characterized by inflammation of the rectal mucosa with proximal, continuous and symmetrical extension through the colon. Its diagnosis is established based on clinical, endoscopic and histological findings. The therapeutic goal is to achieve clinical and endoscopic remission, reduce the risk of colectomy, colorectal cancer and improve quality of life of patients. A search for scientific articles was carried out, achieving this narrative review of the literature where the most relevant and updated aspects of the disease are exposed; with the objective of providing elements for the diagnostic and therapeutic approach of the
disease. 

Downloads

Download data is not yet available.

References

Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. Elsevier health sciences. 10th ed.2018; pp 2030-2031

Kobayashi T, Siegmund B, Le Berre C, Wei S, Ferrante M, Shen B et al. Ulcerative colitis. Nature Reviews Disease Primers. 2020;6(1).

Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. Journal of Gastroenterology. 2018;53(3):305-353.

Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019 Dec;65(12):100851. doi: 10.1016/j.disamonth.2019.02.004. Epub 2019 Mar 2. PMID: 30837080.

Calvet X, Argüelles-Arias F, López-Sanromán A, Cea-Calvo L, Juliá B, De Santos CR, et al. Patients’ perceptions of the impact of ulcerative colitis on social and professional life: Results from the UC-LIFE survey of outpatient clinics in Spain. Patient Prefer Adherence 2018;12:1815–23.

Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, et al. Lifetime economic burden of Crohn’s Disease and Ulcerative Colitis by age at diagnosis. Clin Gastroenterol Hepatol. 2020;18 (4):889-897.e10.

Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res. 2019 Dec 1;2019:7247238. doi: 10.1155/2019/7247238. PMID: 31886308; PMCID: PMC6914932.

Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis.The Lancet 2017 p. 1756–70.

Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: Analysis of changes in disease activity over years. Gastroenterology 1994;107 (1):3–11.

Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011;7 (4):235–41.

Danovitch SH. Fulminant colitis and toxic megacolon. Gastroenterol Clin North Am. 1989;18 (1):73–82.

Desai J, Elnaggar M, Hanfy A, Doshi R. Toxic Megacolon: Background, pathophysiology, management challenges and solutions. 2020.

Lutgens MWMD, van Oijen MGH, van der Heijden GJMG, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013;19 (4):789–99.

Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol 2019;114 (3):384–413.

Bentley E, Jenkins D, Campbell F, Warren B. How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop. J Clin Pathol 2002;55 (12):955–60.

Sherwood R, Walsham N. Fecal calprotectin in inflammatory bowel disease. Clinical and Experimental Gastroenterology. 2016:21.

Mao R, Xiao YL, Gao X, Chen BL, He Y, Yang L, et al. Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies. Inflamm Bowel Dis 2012;18 (10):1894–9.

Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC, et al. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines. J Crohn’s Colitis 2013;7 (7):556–85.

Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant R V., et al. Selecting Therapeutic targets in inflammatory bowel disease (STRIDE): Determining Therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110 (9):1324–38.

Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2010; (1).

Ford AC, Khan KJ, Achkar JP, Moayyedi P. Efficacy of oral vs. Topical, or combined oral and topical 5-aminosalicylates, in ulcerative colitis: Systematic review and meta-analysis. Am J Gastroenterol; 2012 p. 167–76.

Kane S V., Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001;96 (10):2929–33.

Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: The Toronto consensus. Gastroenterology 2015;148 (5):1035-1058.e3.

Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H; IBD guidelines eDelphi consensus group, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019 Dec;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484. Epub 2019 Sep 27. Available from: https://pubmed.ncbi.nlm.nih.gov/31562236/

Rubin DT, Cohen RD, Sandborn WJ, Lichtenstein GR, Axler J, Riddell RH, Zhu C, Barrett AC, Bortey E, Forbes WP. Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis. 2017 Jul 1;11(7):785-791. doi: 10.1093/ecco-jcc/jjx032. Erratum in: J Crohns Colitis. 2017 Dec 4;11(12):1510.

Astó E, Méndez I, Audivert S, Farran-Codina A, Espadaler J. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis. Nutrients. 2019 Jan 30;11(2):293. doi: 10.3390/nu11020293.

A City Park (c. 1887) William Merritt Chase. Estados Unidos, 1849–1916 Art Institute Chicago

Downloads

Published

2020-12-09

How to Cite

Zuluaga Arbeláez, N., Sierra Vargas, E. C., Díaz Coronado, J. C., & Guevara Casallas, L. G. (2020). Ulcerative colitis for non-gastroenterologists. CES Medicina, 34(3), 188–197. https://doi.org/10.21615/cesmedicina.34.3.2

Issue

Vol. 34 No. 3 (2020): CES Medicina

Section

Revisión de tema

License

Copyright (c) 2020 CES Medicina

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Derechos de reproducción (copyright)

Cada manuscrito se acompañará de una declaración en la que se especifique que los materiales son inéditos, que no han sido publicados anteriormente en formato impreso o electrónico y que no se presentarán a ningún otro medio antes de conocer la decisión de la revista. En todo caso, cualquier publicación anterior, sea en forma impresa o electrónica, deberá darse a conocer a la redacción por escrito.

Plagios, duplicaciones totales o parciales, traduccones del original a otro idioma son de responsabilidad exclusiva de los autores el envío.

Los autores adjuntarán una declaración firmada indicando que, si el manuscrito se acepta para su publicación, los derechos de reproducción son propiedad exclusiva de la Revista CES Medicina.

Se solicita a los autores que proporcionen la  información completa acerca de cualquier beca o subvención recibida de una entidad comercial u otro grupo con intereses privados, u otro organismo, para costear parcial o totalmente el trabajo en que se basa el artículo.

Los autores tienen la responsabilidad de obtener los permisos necesarios para reproducir cualquier material protegido por derechos de reproducción. El manuscrito se acompañará de la carta original que otorgue ese permiso y en ella debe especificarse con exactitud el número del cuadro o figura o el texto exacto que se citará y cómo se usará, así como la referencia bibliográfica completa.

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views